Role of histopathology evaluation in pancreas transplantation

Current Opinion in Organ Transplantation

Volumn 7, Issue 2, 2002, Pages 185-190

  Papadimitriou, John C ^a,b   Drachenberg, Cinthia B ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MARYLAND MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; CYCLOSPORIN; TACROLIMUS;

ACINAR CELL; ARTERY OCCLUSION; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DIABETES MELLITUS; DIFFERENTIAL DIAGNOSIS; DRUG TOXICITY; GRAFT FAILURE; GRAFT REJECTION; HEPATIC ARTERY; HEPATIC DUCT; HEPATITIS; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERGLYCEMIA; LIVER PARENCHYMA; LIVER VEIN; MORPHOLOGY; NEEDLE BIOPSY; NONHUMAN; PANCREAS ISLET; PANCREAS ISLET TRANSPLANTATION; PANCREAS RESECTION; PROGNOSIS;

EID: 0036055010     PISSN: 10872418     EISSN: None     Source Type: Journal    
DOI: 10.1097/00075200-200206000-00014     Document Type: Article

References (74)

1. Are kidney and pancreas rejection simultaneous events in combined transplantations in dogs?
2. Differences in rejection grading after simultaneous pancreas and kidney transplantation in pigs
3. Simultaneous pancreas and kidney transplantation rejection: Separate or synchronous events?
4. The frequency of rejection episodes after combined kidney-pancreas transplantation-the impact on graft survival
5. Isolated pancreas rejection in combined kidney pancreas transplantation. Results of percutaneous pancreas biopsy
6. Renal allograft rejection with normal renal function in simultaneous kidney/pancreas recipients: Does dissynchronous rejection really exist?
7. Histologic grading of acute allograft rejection in pancreas needle biopsy. Correlation to serum enzymes, glycemia and response to immunosuppressive treatment
8. Effectiveness of immunosuppressive treatment for recurrent or refractory pancreas allograft rejection: Correlation with histologic grade
9. CT-guided biopsy of pancreas transplantations
10. Role of surveillance biopsies in monitoring recipients of pancreas alone transplantations
11. Evaluation of pancreas transplantation needle biopsy. Reproducibility and revision of histologic grading system
12. Histologic grading of pancreas acute allograft rejection in percutaneous needle biopsies
13. Diagnosis of pancreas allograft rejection in percutaneous needle biopsies from patients with non-immune related graft pathology
14. Early diagnosis and treatment of pancreas allograft rejection
15. Percutaneous biopsy of bladder-drained pancreas transplantations
16. Percutaneous biopsy of pancreas transplantations
17. Equivalent success of simultaneous pancreas kidney and solitary pancreas transplantation. A prospective trial of tacrolimus immunosuppression with percutaneous biopsy
18. Significance of pancreas graft biopsy in detection of rejection
19. Experience with protocol biopsies after solitary pancreas transplantation
20. Pancreas allograft biopsy. Safety of percutaneous biopsy: Results of a large experience
21. Solitary pancreas allografts. The role of percutaneous biopsy and standardized histologic grading system
22. Comparison of azathioprine and mycophenolate mofetil for the prevention of acute rejection in recipients of pancreas transplantation
23. Thymoglobulin induction decreases rejection in solitary pancreas transplantation
24. Improved solitary pancreas transplantation graft survival in the modern immunosuppressive era
25. Pancreas rejection. Significance of histopathologic findings with implications for classification of rejection
26. Histologic diagnosis of rejection by using cystoscopically directed needle biopsy specimens from dysfunctional pancreatoduodenal allografts with exocrine drainage into the bladder
27. Safety and efficacy of cystoscopically directed biopsy in pancreas transplantation
28. Laparoscopic-guided biopsy of pancreatic transplantation allograft
29. Histologic findings in islets of whole pancreas allografts. Lack of evidence for recurrent cell-mediated diabetes mellitus
30. Chronic pancreas allograft rejection: Morphological evidence of progression in needle biopsies and proposal of a grading scheme
31. Reproducibility of histologic grading scheme for chronic pancreas allograft rejection in needle biopsies
32. Revised histologic grading scheme for chronic pancreas allograft rejection in core needle biopsies: Prognostic significance
33. Pancreas transplantation: The histologic morphology of graft loss and clinical correlations
34. Distribution of alpha and beta cells in pancreas allograft biopsies: Correlation with rejection and other pathologic processes
35. Pancreas transplantation
36. Pancreas transplantation pathology: A morphologic, immunohistochemical and electron microscopic comparison of allogeneic grafts with rejection, syngeneic grafts, and chronic pancreatitis
37. Allograft vascular disease: Comparison of heart and other grafted organs
38. Arterioenteric fistula due to cytomegalovirus infection after pancreas transplantation
39. Native and graft pancreatitis following combined pancreas-renal transplantation
40. CMV allograft pancreatitis: Diagnosis, treatment, and histologic features
41. CMV infection and disease in kidney and pancreas transplantation recipients
42. Patterns of cytomegalovirus infection in simultaneous kidney-pancreas transplantation recipients receiving tacrolimus, mycophenolate mofetil, and prednisone with ganciclovir prophylaxis
43. Cytomegalovirus disease recurrence after ganciclovir treatment in kidney and kidney-pancreas transplantation recipients
44. Incidence of CMV infection in simultaneous pancreas and kidney transplantation: Comparative study of two surgical procedures segmental pancreas versus whole bladder-drained pancreas
45. Infectious disease complications of simultaneous pancreas kidney transplantation
46. Identification of histologic features differentiating pancreatic allograft rejection from nonrejection-related pathology in needle biopsies
47. Histological grading scheme for pancreas allograft rejection: Application in the differential diagnosis from other pathologic entities
48. Multicenter randomized trial comparing FK506 and cyclosporin in the prevention of renal allograft rejection: A report of the European FK506 Multicenter Renal Study Group
49. Metabolic effect of cyclosporine A and FK506 in liver transplantation recipients
50. Effect of FK506 on glucose metabolism and insulin in normal rats
51. Morphological and functional changes in islets of Langerhans in FK506-treated rats
52. Islet cell damage associated with tacrolimus and cyclosporine: Morphological features in pancreas allograft biopsies and clinical correlation
53. Results of pancreas transplantation after steroid withdrawal under tacrolimus immunosuppression
54. Recurrence of autoimmune diabetes mellitus in recipients of cadaveric pancreatic grafts
55. Recurrence of disease in pancreas transplantations
56. Recurrent diabetes mellitus in the pancreas iso- and allograft. A light and electron microscopic and immunohistochemical analysis of four cases
57. Serological markers of recurrent beta cell destruction in diabetics patients undergoing transplantation
58. Evidence of recurrent autoimmunity in human allogeneic islet transplantation
59. Prevention of autoimmune islet allograft destruction by engraftment of donor T cells
60. Factors influencing pancreas transplantation outcome: Cox proportional hazard regression analysis of a single institution's experience with 357 cases
61. Surgical complications in solitary pancreas and combined pancreas-kidney transplantations
62. Pancreatic transplantation and vascular graft thrombosis
63. Graft failure after solitary pancreas transplantation
64. Patterns of graft loss following simultaneous kidney-pancreas transplantation
65. Allograft pancreatectomy after pancreas transplantation with systemic-bladder versus portal-enteric drainage
66. Pancreas graft loss caused by intra-abdominal infection. A risk factor for a subsequent pancreas retransplantation
67. Surgical complications in 123 consecutive pancreas transplantation recipients: Comparison of bladder and enteric drainage
68. Vascular graft thrombosis after pancreatic transplantation: Univariate and multivariate operative and nonoperative risk factor analysis
69. Surgical complications after pancreas transplantation with portal-enteric drainage
70. Experimental hyperacute rejection in pancreas allotransplants
71. Epstein-Barr virus-related post-transplantation lymphoproliferative disorder in pancreas allografts: Histologic differential diagnosis from acute allograft rejection